Ticker LaunchUplisting · LIXT
Nomad Power Solutions, Inc.
Formerly LIXTE BIOTECHNOLOGY HOLDINGS, INC.; SRKP 7 INC
Nomad Power Solutions, Inc. (LIXT), already reporting to the SEC, moved up to Nasdaq Capital Market on Nov 27, 2020 with an offering at $4.75 per share. WestPark was lead-left underwriter, joined by WallachBeth Capital. TroyGould advised the company and Sheppard Mullin advised the underwriters.
At its 2020 uplisting, Lixte Biotechnology Holdings, Inc. (now Nomad Power Solutions, Inc.) was a clinical-stage drug discovery company using biomarker technology to find enzyme targets for serious diseases. Its pipeline focused on protein phosphatase inhibitors.
- Status
- Uplisting
- Ticker
- LIXT
- Exchange
- Nasdaq Capital Market
- Listed
- Nov 27, 2020
- Price
- $4.75
- Market cap at IPO price
- $58.8M
- First filed
- Sep 3, 2020
- Underwriters
- WestPark and WallachBeth Capital
- Company counsel
- TroyGould
- Underwriters' counsel
- Sheppard Mullin
- Sector
- Biotech & pharma
- Country / state
- FL
More on this listing for subscribers
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Sep 3, 2020
- Latest amendment Nov 16, 2020
- Final prospectus (424B4) Nov 27, 2020
- All filings on EDGAR CIK 1335105
Other Biotech & pharma uplistings in 2020
- Cyclo Therapeutics, Inc.CTDH · Dec 11, 2020 · $12.5M
- Processa Pharmaceuticals, Inc.PCSA · Oct 5, 2020 · $19.2M
- GeoVax Labs, Inc.GOVX · Sep 28, 2020 · $12.8M
- Biovie Inc.BIVI · Sep 18, 2020 · $15.7M
- Panbela Therapeutics, Inc.SNBP · Aug 31, 2020
- Windtree Therapeutics Inc /de/WINTD · May 21, 2020 · $20M